| Product Name | MF | CAS | Details |
|---|
| Canrenone | C22H28O3 | 976-71-6 | Details |
| (3,5-di-benzyloxy)benzoic acid benzyl ester | C28H24O4 | 50513-72-9 | Details |
| 5-R-Rivaroxaban | C19H18ClN3O5S | 865479-71-6 | Details |
| 4-tert-ButylaMinoethyl-2-Methylphenol | C13H21NO | 132183-64-3 | Details |
| 1-(6-amino-3,5-difluoropyridin-2-yl)-6,8-difluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; delafloxacin impurity | C17H12ClF3N4O2 | 2097714-12-8 | Details |
| Paricalcitol | C27H44O3 | 131918-61-1 | Details |
| (3alpha,14beta,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid | C20H24N2O3 | 28152-73-0 | Details |
| 11-a-Hydroxy canrenone methyl ester | C24H32O6 | 192704-56-6 | Details |
| Fulvestrant 9-Sulfone | C32H47F5O4S | 98008-06-1 | Details |
| Fluticasone propionate | C25H31F3O5S | 80474-14-2 | Details |
| 21-Dehydro Budesonide | C25H32O6 | 85234-63-5 | Details |
| Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) | C13H21NO2 | 18910-68-4 | Details |
| 2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | C19H19N3O5S | 1415566-28-7 | Details |
| AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | C16H19N3O5 | 1429334-00-8 | Details |
| methyl 3,5-bis(benzyloxy)benzoate | C22H20O4 | 58605-10-0 | Details |
| Fulvestrant Sterol DiMer | Details |
| 9-(2'-ACETOXYETHOXYMETHYL)-GUANINE | C10H13N5O4 | 102728-64-3 | Details |
| 4-Benzyl Albuterol | C20H27NO3 | 56796-66-8 | Details |
| Calcium Levofolinate EP Impurity I | C20H23N7O6 | 31690-11-6 | Details |
| 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride | C15H23NO2 | 93413-77-5 | Details |
| 1,2-Dihydro Fluticasone Propionate | C25H33F3O5S | 105613-90-9 | Details |
| 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile | C15H19N3O5 | 675126-26-8 | Details |
| (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | C11H18N2O3 | 361440-67-7 | Details |
| Folic Acid EP Impurity C | C19H19N7O6 | 47707-78-8 | Details |
| N-Methyl OMeprazole (Mixture of isoMers with the Methylated nitrogens of iMidazole) | C18H21N3O3S | 89352-76-1 | Details |
| Folic Acid EP Impurity E | C26H24N12O7 | 1391068-26-0 | Details |
| DesfluoroMethyl Fluticasone Propionate Disulfide | C48H58F4O10S2 | 201812-64-8 | Details |
| Di-Norbudesonide (Mixture of DiastereoMers) | C23H30O6 | 1040085-98-0 | Details |
| 5-O-DESMETHYL OMEPRAZOLE | C16H17N3O3S | 151602-49-2 | Details |
| Levalbuterol Related Compound E HCl | C15H26ClNO3 | 69716-64-9 | Details |
| 3-oxo-17α-pregn-4-ene-7α,9:21,17-dicarbolactone | Details |
| (6a,11b,16a,17a)-6,9-Difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid | C21H26F2O5 | 28416-82-2 | Details |
| (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide | C17H19FN2O2 | 133865-88-0 | Details |
| t-Butylnorsynephrine | C12H19NO2 | 96948-64-0 | Details |
| Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
| Sugammadex sodium | C72H104Na8O48S8 | 343306-79-6 | Details |
| Fluticasone Acetate | C24H29F3O5S | 80474-24-4 | Details |
| Ticabesone Propionate | C25H32F2O5S | 73205-13-7 | Details |
| 16α-Butyloxyprednisolone (Budenoside IMpurity) | C25H34O7 | 113930-13-5 | Details |
| Eplerenone EP Impurity B | C24H30O6 | 192704-82-8 | Details |
| 6,6'-bis(2-methyl-2H-tetrazol-5-yl)-3,3'-bipyridine | C14H12N10 | 2095840-91-6 | Details |
| BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID | C15H19F2NO4 | 269396-59-0 | Details |
| Eplerenone | C24H30O6 | 107724-20-9 | Details |
| 2-(tert-butylamino)-1-(3,5-dihydroxyphenyl)ethanone | C12H17NO3 | 139508-58-0 | Details |
| Dexmedetomidine hydrochloride | C13H17ClN2 | 145108-58-3 | Details |
| D,L N-Desmethylvenlafaxine | C16H25NO2 | 149289-30-5 | Details |
| Maropitant Citrate | C38H48N2O8 | 359875-09-5 | Details |
| 4-HYDROXY-3-(HYDROXYMETHYL)BENZALDEHYDE | C8H8O3 | 54030-32-9 | Details |
| 5-(4-methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane | C17H25NO2 | 93413-70-8 | Details |
| Albuterol Aldehyde | C13H19NO3 | 156339-88-7 | Details |
| 2-Amino-4-Methoxy-5-(3-Morpholinopropoxy)benzonitrile | C15H21N3O3 | 675126-27-9 | Details |
| Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) | C14H23NO3 | 18910-70-8 | Details |
| SalbutaMol DiMer | C26H40N2O5 | 149222-15-1 | Details |
| (S)-2-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-4-benzylMorpholin-3-one | C21H19F6NO3 | 327623-36-9 | Details |
| 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-((3-chloro-2-hydroxypropyl)amino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid； delafloxacin impurity | Details |
| alpha-[(benzyl-tert-butylamino)methyl]-m-xylene-4,alpha,alpha'-triol | C20H27NO3 | 24085-03-8 | Details |
| 5-Bromoacetyl-2-hydroxybenzaldehyde | C9H7BrO3 | 115787-50-3 | Details |
| Boc-3-Hydroxy-1-adamantyl-D-glycine | C17H27NO5 | 361442-00-4 | Details |
| (7β,11α,17α)-9,11-Epoxy-17-hydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic Acid γ-Lactone Methyl Ester | C24H30O6 | 209253-81-6 | Details |
| Fluticasone EP IMpurity B | C24H30F2O6S | 948566-12-9 | Details |
| (S)-Tedizolid | C17H15FN6O3 | 1431699-67-0 | Details |
| SalbutaMol IMpurity K | C13H18ClNO3 | 898542-80-8 | Details |
| Bendamustine Impurity D | C16H20ClN3O2S | 191939-34-1 | Details |
| 2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid | C10H10N4O3S2 | 2036283-13-1 | Details |
| Salbutamol Impurity 6 | C15H25NO3 | 870076-73-6 | Details |
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | C20H25N3O3 | 545445-44-1 | Details |
| Albuterol Methyl Ether | C14H23NO3 | 870076-72-5 | Details |
| 2-Keto ZolpideM | C19H19N3O2 | 400038-68-8 | Details |
| SalbutaMon Hydrochloride | C13H20ClNO3 | 41489-89-8 | Details |
| 7β-Fulvestrant | C32H47F5O3S | 407577-53-1 | Details |
| 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-3-hydroxy-7-(3-hydroxyazetidin-1-yl)-4(1H)-quinolinone； delafloxacin impurity | Details |
| 6-Keto Fulvestrant; Fulvestrant EP Impurity F | Details |
| 3,5-dibenzyloxybenzoic acid | C21H18O4 | 28917-43-3 | Details |
| 3,5-Dihydroxybenzoic acid | C7H6O4 | 99-10-5 | Details |
| FLUTICASONE PROPIONATE, 17-BETA CARBOXYLIC ACID | C24H30F2O6 | 65429-42-7 | Details |
| macitentan | C19H20Br2N6O4S | 441798-33-0 | Details |
| 1-carbomethoxy-3,5-dihydroxybenzene | C8H8O4 | 2150-44-9 | Details |
| 21-Acetoxy-11β-hydroxy-16α,17α-propylmethylenedioxpregna-1,4-diene-3,20-dione | C27H36O7 | 51333-05-2 | Details |
| Fluticasone Dimer Impurity | C43H51F5O8S | 220589-37-7 | Details |
| Folinic Acid EP Impurity E | C15H16N6O4 | 944737-05-7 | Details |
| (R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one | C17H14ClFN6O2 | 1239662-46-4 | Details |
| Fulvestrant Extended | Details |
| 2-(3,5-dihydroxyphenyl)-2-hydroxyacetic acid | C8H8O5 | 52238-36-5 | Details |
| (7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester | C24H30O5 | 95716-70-4 | Details |
| 2-[(1,1-DIMETHYLETHYL)(PHENYLMETHYL)AMINO]-1-[4-HYDROXY-3-(HYDROXY-METHYL)PHENYL]ETHANONESALBUTAMOL | C20H25NO3 | 64092-10-0 | Details |
| 1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- | C22H19N3O6 | 446292-08-6 | Details |
| (R)-Omeprazole Sodium Salt | C17H18N3NaO3S | 161796-77-6 | Details |
| 2-(((3ar,4s,6r,6as)-6-aminotetrahydro-2,2-dimethyl-4h-cyclopenta-1,3-dioxol-4-yl)oxy)-ethanol (2r,3r)-2,3-dihydroxybutanedioate | C14H25NO10 | 376608-65-0 | Details |
| Albuterol diMer | C26H40N2O5 | 147663-30-7 | Details |
| (16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione | C25H32O6 | 216453-74-6 | Details |
| folic Acid impurity H | C20H23N7O7 | Details |
| 11-Oxo Fluticasone Propionate | C25H29F3O5S | 1219174-94-3 | Details |
| (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione | C22H24F2O5S | 219719-95-6 | Details |
| 1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | C36H36N6O10 | 1365267-36-2 | Details |
| 3-hydroxy-5-benzyloxybenzoic acid | C14H12O4 | 159506-17-9 | Details |
| BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID | C16H15F6N5O | 486549-98-7 | Details |
| 7-methyl hydrogen 17α-hydroxy-3-oxopregna-4,11-diene-7α,21-dicarboxylate, γ-lactone | C24H30O5 | 192704-70-4 | Details |
| 1-(3-(benzyloxy)-5-hydroxyphenyl)ethanone | C15H14O3 | 81732-54-9 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||